Cantor Fitzgerald Reiterates Overweight on Roivant Sciences, Maintains $15 Price Target
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Roivant Sciences (NASDAQ:ROIV) and maintained a $15 price target.
August 31, 2023 | 1:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Roivant Sciences has received an Overweight rating from Cantor Fitzgerald, with a maintained price target of $15.
The Overweight rating from Cantor Fitzgerald indicates a positive outlook for Roivant Sciences. The maintained price target of $15 suggests that the analyst believes the stock is undervalued at current levels, which could lead to upward price movement in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100